Police, firefighters train to help Alzheimer's, dementia patients KFVS He acknowledged alarming statistics that 70 percent of people with dementia will wander from their home at some point. "These are people that have served our communities that have done a lot for us," said Chief Hunt. "They are our family members too ... |
Day: March 24, 2015
Is drug industry on the right track in Alzheimer’s research? – SFGate
NBCNews.com | Is drug industry on the right track in Alzheimer's research? SFGate The researchers examined more than 3,600 brains from patients who died at different stages of dementia, with Alzheimer's confirmed in almost 1,400. Measuring amyloid and tau in the brains at various stages of disease progression allowed them to ... Ethicist: Why a New Alzheimer's Drug Isn't A No-Brainer Can Biogen Change How We View Alzheimer's Disease? |
Ethicist: Why a New Alzheimer’s Drug Isn’t A No-Brainer – NBCNews.com
NBCNews.com | Ethicist: Why a New Alzheimer's Drug Isn't A No-Brainer NBCNews.com In a very early stage safety test aducanumab slowed the cognitive decline and dementia associated with Alzheimer's in people. On the Mini Mental Status Exam, a widely used measure of cognitive function, people at risk of Alzheimer's who got a placebo ... Alzheimer's debate revived as Biogen's drug trial advances Potential Alzheimer's drug further backs protein hypothesis |
‘MIND’ Your Diet, and Protect Against Alzheimer’s – Live Science
Live Science | 'MIND' Your Diet, and Protect Against Alzheimer's Live Science Alzheimer's disease, the most common form of dementia, affects more than 40 million people globally, according to Alzheimer's Disease International. Among developed nations, the prevalence rates tend to be highest in North America and northern Europe ... The MIND diet provides some good news in the fight against Alzheimer's New MIND diet lowers risk of developing Alzheimer's Disease by 53 percent! Food for the mind |
Alzheimer’s Debate Revived Even as Biogen’s Drug Trial Advances – Bloomberg
Bloomberg | Alzheimer's Debate Revived Even as Biogen's Drug Trial Advances Bloomberg The researchers examined more than 3,600 brains from patients who died at different stages of dementia, with Alzheimer's confirmed in almost 1,400. Measuring amyloid and tau in the brains at various stages of disease progression allowed them to ... Alzheimer's: Tau, Not Amyloid, Is The Primary Driver Study: Progression of dysfunctional tau protein drives cognitive decline in ... Mayo Clinic Study of Thousands of Brains Reveals Tau as Driver of Alzheimer's ... |